Educaciòn Mèdica Continuada CME 2017 Alergia y Asma

En  Nicaragua no  tenemos  una  Regulaciòn a nivel nacional  sobre mìnimos  de  EMC. ( Horas  Crèdito ).  Algunos  hospitales pùblicos y privados ,  hacen  sus propias  actividades  y  reconocen  las actividades propuestas  por   las instituciones  de  Estados Unidos  y Europeas que  acreditan  las  diversas especialidades..

Quiero proponer a  los  estudiosos del Asma  y Patologìas  Alèrgicas ( pediatras ,internistas,  pneumòlogos, alergòlogos , inmunòlogos), una  serie  ECM, en distintas  modalidades,
Completamente  gratis, en  linea, de prestigiosas, instituciones;
Baylor College, Albert Einstein, Cleveland Clìnic,  Pensylvannia  University  y otras  organizaciones profesionales.


Emerging Interleukin-5 (IL-5) Antagonists Based Therapies for Eosinophilic Asthma

Webcast      Expires

October 31, 2017

http://www.mycme.com/emerging-interleukin-5-il-5-antagonists-based-therapies-
for-eosinophilic-asthma/activity/4363/

Online Case-Based Lesson: Asthma

Faculty: Alexander Rae-Grant, MD; Marianne J Sumego, MD
Length: 15 minutes
Release Date: 05/07/2014
Expiration Date: 05/07/2017

Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma

 Begin

CME Credit

1.00

Expires

07/20/2017

Upon completion of this activity, participants should be better able to:

• Identify NAEPP EPR-3 and GINA guidelines and recommendations to control patients' symptoms, reduce exacerbations, and improve quality of life of patients with poorly controlled asthma
• Apply emerging immunotherapeutic strategies in patients with poorly controlled asthma

Personalized Approaches for Severe Asthma

http://www.mycme.com/targeting-inflammatory-pathways implementing-personalized-approaches-for-severe-asthmayour-questions-answered/activity/3996/

Webcast

EXPIRES  May 26, 2017

Targeting Inflammatory Pathways: Implementing 

New Managing Moderate-to-Severe Atopic Dermatitis in Adults: Pathology-Based, Targeted Therapies  Begin CME Credit Hour 1.00 Expires 02/24/2018 After completing the CME activity, learners should be better able to: Explain how dysfunction of specific immunologic factors and pathways contributes to the pathophysiology of moderate-to-severe atopic dermatitis (AD) in adults. Review approaches for the assessment and diagnosis of moderate-to-severe AD in adults that account for biomarkers, comorbidities, and the overall disease burden. Discuss proactive versus reactive approaches for the management of moderate-to-severe AD in adults. Review the challenges posed by traditional standard-of-care therapies and the efficacy and safety of new and emerging treatment options.  PatientGPS™: Clinical Paths in the Management of Patients with COPD  Begin CME Credit 1.00 Expires 12/28/2017 As the third leading cause of death in the United States, chronic obstructive pulmonary disease (COPD) can substantially affect a patient’s quality of life and creates a significant burden on society as a whole. Despite advancements in the understanding of the disease and newer treatment options, successful management of the patient with COPD remains challenging. From diagnosis and assessment, to identifying and addressing adherence, healthcare professionals who treat COPD are confronted with many barriers to optimal care. Successful management, however, can lead to improvements in patient morbidity and mortality, as well as decreases in healthcare expenditures and hospitalization. To address many of these challenges, National Jewish Health and Catamount Medical Education have developed PatientGPS™: Clinical Paths in the Management of Patients with COPD

3.65 / 4.00

Online Journal Article - Alpha-1 antitrypsin deficiency: An underrecognized, treatable cause of COPD

Author: James Stoller, MD
CME: Yes
Length: 1 hour
Release Date: 7/1/2016 12:00:00 AM
Expiration Date: 06/30/2017

New Managing Moderate-to-Severe Atopic Dermatitis in Adults: Pathology-Based, Targeted Therapies

 Begin

CME Credit Hour

1.00

Expires

02/24/2018

After completing the CME activity, learners should be better able to:

• Explain how dysfunction of specific immunologic factors and pathways contributes to the pathophysiology of moderate-to-severe atopic dermatitis (AD) in adults.
• Review approaches for the assessment and diagnosis of moderate-to-severe AD in adults that account for biomarkers, comorbidities, and the overall disease burden.
• Discuss proactive versus reactive approaches for the management of moderate-to-severe AD in adults.
• Review the challenges posed by traditional standard-of-care therapies and the efficacy and safety of new and emerging treatment options.

3.59 / 4.00

Online Journal Article - An 85-year-old woman with respiratory failure and positional hypoxemia

Author: Alpana Senapati, DO; Hardeep Rai, MD; Abhijit Duggal, MD
CME: Yes
Length: 1 hour
Release Date: 5/1/2016 12:00:00 AM
Expiration Date: 04/30/2017

3.66 / 4.00

Online Journal Article - Treating and preventing acute exacerbations of COPD

Author: Loutfi Aboussouan, MD; Umur Hatipoglu, MD
CME: Yes
Length: 1 hour
Release Date: 4/1/2016 12:00:00 AM
Expiration Date: 03/31/2017

Top Rated

3.7 / 4.00

Online Webcast - Alpha-1 Antitrypsin Deficiency: State of the Art, Part 2 
Faculty: James Stoller, MD
CME: Yes
Length: 15 minutes
Release Date: 09/03/2014
Expiration Date: 09/03/2017

3.67 / 4.00

Online Webcast - Cholesterol Lowering Agents 

Faculty: Katherine Greenlee, PharmD / RPh

CME: Yes

Length: 1 hour

Release Date: 10/01/2014

Expiration Date: 10/01/2017

Feliz  fin  de  semana.